{"nct_id":"NCT02203851","title":"Extension Trial Assessing the Safety and Efficacy of BI 655066/ABBV-066/Risankizumab in Patients With Moderate to Severe Chronic Plaque Psoriasis","status":"COMPLETED","status_verified_date":"2019-10","start_date":"2014-11-20","start_date_type":"ACTUAL","primary_completion_date":"2018-09-04","primary_completion_date_type":"ACTUAL","completion_date":"2018-09-04","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["ABBV"]}